Stig E. Bojesen

46.7k total citations · 1 hit paper
172 papers, 8.3k citations indexed

About

Stig E. Bojesen is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Stig E. Bojesen has authored 172 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 50 papers in Oncology and 29 papers in Physiology. Recurrent topics in Stig E. Bojesen's work include Studies on Chitinases and Chitosanases (18 papers), Telomeres, Telomerase, and Senescence (17 papers) and BRCA gene mutations in cancer (13 papers). Stig E. Bojesen is often cited by papers focused on Studies on Chitinases and Chitosanases (18 papers), Telomeres, Telomerase, and Senescence (17 papers) and BRCA gene mutations in cancer (13 papers). Stig E. Bojesen collaborates with scholars based in Denmark, United States and United Kingdom. Stig E. Bojesen's co-authors include Børge G. Nordestgaard, Anne Tybjærg‐Hansen, Shoaib Afzal, Jonas B. Nielsen, Maren Weischer, Kristine H. Allin, Line Rode, Julia S. Johansen, David D. Ørsted and Henrik Birgens and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Stig E. Bojesen

165 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Statin Use and Reduced Cancer-Related Mortality

2012 773 citations Børge G. Nordestgaard, Stig E. Bojesen et al. profile →

Peers

Countries citing papers authored by Stig E. Bojesen

Since Specialization

Citations

This map shows the geographic impact of Stig E. Bojesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stig E. Bojesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stig E. Bojesen more than expected).

Fields of papers citing papers by Stig E. Bojesen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stig E. Bojesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stig E. Bojesen. The network helps show where Stig E. Bojesen may publish in the future.

Co-authorship network of co-authors of Stig E. Bojesen

This figure shows the co-authorship network connecting the top 25 collaborators of Stig E. Bojesen. A scholar is included among the top collaborators of Stig E. Bojesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stig E. Bojesen. Stig E. Bojesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The prognostic role of circulating CA19–9 and CEA in patients with colorectal cancer 2025 ·Cancer Treatment and Research Communications ·(unknown), (unknown), Jakob Vasehus Schou, (unknown), (unknown), Jakob Lykke, Dorte Nielsen, Per Pfeiffer, Camilla Qvortrup, Mette Yilmaz, Ole Larsen, Stig E. Bojesen, Benny Vittrup Jensen, Julia S. Johansen	2
2	Circulating tumor DNA for surveillance in high-risk melanoma patients: a study protocol 2025 ·Acta Oncologica ·(unknown), (unknown), Karin Dreisig, Tim Svenstrup Poulsen, Christoffer Johansen, Thomas Litman, Stig E. Bojesen, Estrid Høgdall, Annette H. Chakera, Lisbet Rosenkrantz Hölmich	1
3	Alcohol consumption and risk of psoriasis: Results from observational and genetic analyses in more than 100,000 individuals from the Danish general population 2024 ·JAAD International ·(unknown), (unknown), Signe Vedel‐Krogh, Stig E. Bojesen, Lone Skov	0
4	Attitudes towards risk-stratified breast cancer screening in Denmark – a qualitative study 2024 ·BMC Cancer ·(unknown), Claus Rasmussen, (unknown), Stig E. Bojesen, Janne Bigaard	1
5	1893P Incidence of myocardial ischemia during treatment with capecitabine: Assessment with Holter recording and cardiac biomarkers 2024 ·Annals of Oncology ·Anne Dyhl-Polk, Morten Schou, Kirsten Vistisen, (unknown), Stig E. Bojesen, (unknown), Merete Vaage‐Nilsen, Dorte Nielsen	0
6	Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer 2024 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Stig E. Bojesen, Julia S. Johansen, Bent Ejlertsen, Tobias Berg, Malgorzata Tuxen, Kasper Madsen, Hella Danø, Henrik Flyger, Maj‐Britt Jensen, Dorte Nielsen	1
7	Aryl hydrocarbon receptor repressor (AHRR) methylation predicts risk of vascular disease: A cohort study of the general population 2024 ·International Journal of Surgery ·(unknown), Camilla J. Kobylecki, (unknown), Stig E. Bojesen	2
8	Adherence to general national dietary guidelines and risk of psoriasis: results from a general population study of 105 332 individuals 2024 ·Clinical and Experimental Dermatology ·(unknown), Emilie Westerlin Kjeldsen, Signe Vedel‐Krogh, Stig E. Bojesen, Lone Skov	0
9	Changing Smoking Behavior and Epigenetics 2023 ·CHEST Journal ·(unknown), Camilla J. Kobylecki, (unknown), Stig E. Bojesen	8
10	Allostatic load as predictor of mortality: a cohort study from Lolland-Falster, Denmark 2022 ·BMJ Open ·(unknown), George Napolitano, Christian Fynbo Christiansen, Stig E. Bojesen, Christina Ellervik, Randi Jepsen, Knud Rasmussen, Elsebeth Lynge	10
11	Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification 2021 ·Clinical Cancer Research ·(unknown), Zsófia Sztupinszki, (unknown), Inna M. Chen, Astrid Z. Johansen, Benny Vittrup Jensen, Stig E. Bojesen, Dorte Nielsen, Carsten Palnæs Hansen, Jane P. Hasselby, Kaspar René Nielsen, Zoltán Szállási, Julia S. Johansen	22
12	Breast cancer risk factors and their effects on survival: a Mendelian randomisation study 2020 ·BMC Medicine ·(unknown), Anna Morra, Sander Canisius, Jenny Chang‐Claude, Siddhartha Kar, Wei Zheng, Stig E. Bojesen, Doug Easton, Paul D.P. Pharoah, Marjanka K. Schmidt	57
13	Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population‐based cohort studies and two‐sample Mendelian randomization analyses 2020 ·International Journal of Cancer ·Jue‐Sheng Ong, Eske M. Derks, Mikael Eriksson, Jiyuan An, Liang‐Dar Hwang, Douglas F. Easton, Paul D.P. Pharoah, Andrew Berchuck, Linda E. Kelemen, Keitaro Matsuo, Georgia Chenevix‐Trench, Per Hall, Stig E. Bojesen, Penelope M. Webb, Stuart MacGregor	11
14	AHRR hypomethylation as an epigenetic marker of smoking history predicts risk of myocardial infarction in former smokers 2020 ·Atherosclerosis ·Anne Langsted, Stig E. Bojesen, Erik S.G. Stroes, Børge G. Nordestgaard	10
15	Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer 2019 ·Cancer Epidemiology Biomarkers & Prevention ·Inna M. Chen, Astrid Z. Johansen, Christian Dehlendorff, Benny Vittrup Jensen, Stig E. Bojesen, Per Pfeiffer, Jon Kroll Bjerregaard, Svend Erik Nielsen, (unknown), Niels Henrik Holländer, Mette Yilmaz, (unknown), Julia S. Johansen	12
16	Smoking, blood cells and myeloproliferative neoplasms: meta‐analysis and Mendelian randomization of 2·3 million people 2019 ·British Journal of Haematology ·(unknown), Alisa D. Kjærgaard, Kasper Mønsted Pedersen, Anders Lindholm Sørensen, Marie Bak, (unknown), Børge G. Nordestgaard, Stig E. Bojesen, Yunus Çolak, Vibe Skov, Lasse Kjær, Janne Schurmann Tolstrup, Hans Carl Hasselbalch, Christina Ellervik	27
17	AHRR(cg05575921) hypomethylation marks smoking behaviour, morbidity and mortality 2017 ·Thorax ·Stig E. Bojesen, Nicholas J. Timpson, Caroline L. Relton, George Davey Smith, Børge G. Nordestgaard	107
18	Short Telomere Length and Ischemic Heart Disease: Observational and Genetic Studies in 290 022 Individuals 2016 ·Clinical Chemistry ·(unknown), Line Rode, Børge G. Nordestgaard, Stig E. Bojesen	84
19	Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population 2011 ·British Journal of Cancer ·Kristine H. Allin, Stig E. Bojesen, Julia S. Johansen, Børge G. Nordestgaard	29
20	The JAK2 V617F somatic mutation, mortality and cancer risk in the general population 2010 ·Haematologica ·(unknown), Henrik Birgens, Børge G. Nordestgaard, Lasse Kjær, Stig E. Bojesen	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact